網膜色素変性症治療薬UF-021の第III相有効性および安全性臨床試験

基本情報

NCT ID: NCT01786395
ステータス: 中止
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 202
治験依頼者名: R-Tech Ueno, Ltd.

概要

This study is a multicenter trial performed in Japan, consisting of a comparative study period and a continuous administration period. Effect of 0.15% UF-021 eye drops on improvement in central retinal sensitivity with HFA will be verified in 52 weeks comparative study period by a placebo-controlled, double-masked study in patients with retinitis pigmentosa. The safety of same eye drops will also be examined in 52 weeks continuous administration period, in all the patients who completed the comparative study period.

対象疾患

Retinitis Pigmentosa

介入

UF-021(DRUG)

Placebo(DRUG)

依頼者（Sponsor）

R-tech Ueno(INDUSTRY)